menu
    • menu

    Company profile for MyMD Pharmaceuticals

    NEW Drugs in Dev: 4
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MyMD is a clinical-stage pharmaceutical company focused on the development of drug products that represent a transformation in the targeting of aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety and sleep disorders. Our team has partnered with academic founders and key opinion leaders to identify synthetic therapeutics, including the first drug being designed to significantly increase human lifespan...
    MyMD is a clinical-stage pharmaceutical company focused on the development of drug products that represent a transformation in the targeting of aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety and sleep disorders. Our team has partnered with academic founders and key opinion leaders to identify synthetic therapeutics, including the first drug being designed to significantly increase human lifespan.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MyMD PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    855 N Wolfe St, Ste 623 Baltimore, Maryland 21205
    Telephone
    Telephone
    (813) 864-2566
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mymd.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TNF Pharmaceuticals Begins Trading Under New Symbol
    TNF Pharmaceuticals Begins Trading Under New Symbol "TNFA"

    24 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240724213342/en

    BUSINESSWIRE
    24 Jul 2024
    Share Share
    MyMD Pharmaceuticals Rebrands As TNF Pharmaceuticals, Inc
    MyMD Pharmaceuticals Rebrands As TNF Pharmaceuticals, Inc

    22 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240722253499/en

    BUSINESSWIRE
    22 Jul 2024
    Share Share
    MyMD Appoints Mitchell Glass As President And Chief Medical Officer
    MyMD Appoints Mitchell Glass As President And Chief Medical Officer

    17 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240617357457/en

    BUSINESSWIRE
    17 Jun 2024
    Share Share
    MyMD Pharmaceuticals Secures Strategic Investments
    MyMD Pharmaceuticals Secures Strategic Investments

    21 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240521024499/en

    BUSINESSWIRE
    21 May 2024
    Share Share
    MyMD Regains Compliance with Nasdaq Minimum Bid Price Requirement
    MyMD Regains Compliance with Nasdaq Minimum Bid Price Requirement

    05 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240305851820/en

    BUSINESSWIRE
    05 Mar 2024
    Share Share
    MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
    MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

    13 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240213384915/en

    BUSINESSWIRE
    13 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search